Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...

The technology is said to “power” the t:slim X2 and Tandem Mobi, the company’s insulin delivery systems. Tandem Diabetes Care president and CEO John Sheridan said: “We have seen firsthand ...

Our pump portfolio features the Tandem Mobi and t:slim X2, both of which feature Control-IQ advanced hybrid closed-loop technology. Our headquarters are in San Diego, California. We consider our ...

Control-IQ+, compatible with both the t:slim X2 insulin pump and Tandem Mobi System, is now available for people with type 1 diabetes ages 2 years and older and adults with type 2 diabetes.

Tandem Diabetes launches Control-IQ+ technology commercially in the United States. Control-IQ+ is compatible with t:slim X2 ...

Tandem Diabetes (TNDM) announced the United States commercial launch of Control-IQ+ technology, the latest generation of the company’s advanced ...

Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.

1,2 Control-IQ powers both Tandem insulin delivery systems – the t:slim X2 and Tandem Mobi – to provide proven, best-in-class outcomes. Results from major studies of Tandem’s technology in ...

Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States ...